Oncotelic Therapeutics, Inc. (OTLC) stock
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics cash
Cash and short-term investments held at the end of each period.
Oncotelic Therapeutics's cash was $186.01K at Jun 30, 2026. For fiscal 2025 it was $88.86K, up 3.2% from the year before. Over ten years it grew -43.6% a year on average. The highest annual figure on record is $30.03M in fiscal 2014.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.86K | +3.2% |
| FY2024 | Dec 31, 2024 | $86.13K | -49.5% |
| FY2023 | Dec 31, 2023 | $170.41K | -29.4% |
| FY2022 | Dec 31, 2022 | $241.45K | -57.5% |
| FY2021 | Dec 31, 2021 | $568.77K | +20.0% |
| FY2020 | Dec 31, 2020 | $474.02K | +478.3% |
| FY2019 | Dec 31, 2019 | $81.96K | +3181.2% |
| FY2018 | Dec 31, 2018 | $2.50K | -99.8% |
| FY2017 | Dec 31, 2017 | $1.12M | -90.7% |
| FY2016 | Dec 31, 2016 | $12.00M | -56.0% |
| FY2015 | Dec 31, 2015 | $27.29M | -9.1% |
| FY2014 | Dec 31, 2014 | $30.03M | +328.7% |
| FY2013 | Dec 31, 2013 | $7.01M | +41.6% |
| FY2012 | Dec 31, 2012 | $4.95M | -50.4% |
| FY2011 | Dec 31, 2011 | $9.97M | +116.7% |
| FY2010 | Dec 31, 2010 | $4.60M | -67.0% |
| FY2009 | Dec 31, 2009 | $13.93M | -23.8% |
| FY2008 | Dec 31, 2008 | $18.28M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $186.01K | +134.9% |
| Q1 FY2026 | Mar 31, 2026 | $63.61K | -26.1% |
| Q4 FY2025 | Dec 31, 2025 | $88.86K | -40.4% |
| Q2 FY2025 | Jun 30, 2025 | $88.02K | +21.9% |
| Q1 FY2025 | Mar 31, 2025 | $79.17K | -58.1% |
| Q4 FY2024 | Dec 31, 2024 | $86.13K | -49.5% |
| Q3 FY2024 | Sep 30, 2024 | $149.02K | -44.4% |
| Q2 FY2024 | Jun 30, 2024 | $72.22K | -60.3% |
| Q1 FY2024 | Mar 31, 2024 | $188.99K | -0.8% |
| Q4 FY2023 | Dec 31, 2023 | $170.41K | -29.4% |
| Q3 FY2023 | Sep 30, 2023 | $268.02K | +5.6% |
| Q2 FY2023 | Jun 30, 2023 | $181.87K | -54.5% |
| Q1 FY2023 | Mar 31, 2023 | $190.44K | +94.5% |
| Q4 FY2022 | Dec 31, 2022 | $241.45K | -57.5% |
| Q3 FY2022 | Sep 30, 2022 | $253.88K | +225.2% |
| Q2 FY2022 | Jun 30, 2022 | $399.77K | -13.3% |
| Q1 FY2022 | Mar 31, 2022 | $97.91K | -88.2% |
| Q4 FY2021 | Dec 31, 2021 | $568.77K | +20.0% |
| Q3 FY2021 | Sep 30, 2021 | $78.08K | -94.3% |
| Q2 FY2021 | Jun 30, 2021 | $461.29K | -30.2% |
| Q1 FY2021 | Mar 31, 2021 | $830.72K | +352.9% |
| Q4 FY2020 | Dec 31, 2020 | $474.02K | +478.3% |
| Q3 FY2020 | Sep 30, 2020 | $1.36M | +8305.5% |
| Q2 FY2020 | Jun 30, 2020 | $660.90K | +684.2% |
| Q1 FY2020 | Mar 31, 2020 | $183.44K | -8.3% |
| Q4 FY2019 | Dec 31, 2019 | $81.96K | +3181.2% |
| Q3 FY2019 | Sep 30, 2019 | $16.21K | -98.5% |
| Q2 FY2019 | Jun 30, 2019 | $84.27K | -95.7% |
| Q1 FY2019 | Mar 31, 2019 | $200.00K | -14.2% |
| Q4 FY2018 | Dec 31, 2018 | $2.50K | -99.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.06M | -44.5% |
| Q2 FY2018 | Jun 30, 2018 | $1.97M | -60.7% |
| Q1 FY2018 | Mar 31, 2018 | $233.00K | -97.2% |
| Q4 FY2017 | Dec 31, 2017 | $1.12M | -90.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.91M | -88.3% |
| Q2 FY2017 | Jun 30, 2017 | $5.00M | -74.1% |
| Q1 FY2017 | Mar 31, 2017 | $8.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $16.28M | – |
| Q2 FY2016 | Jun 30, 2016 | $19.34M | – |
See a number that looks wrong?